Journavx, a new non-opioid pain medication, offers a safer alternative for managing acute pain while reducing the risk of ...

Experts discuss the current research on the use of digital therapeutics for managing chronic pain in rheumatic disease.

A new opioid-free pain medication was approved by the FDA on Thursday, marking a non-addictive alternative for patients.

Ahead of this weekend's Super Bowl, some good news for the athletes: NFL players are largely avoiding opioid-based pain ...

New research from McGill University reveals that listening to music at your own rhythm can significantly reduce pain.

On Wednesday, the U.S. Food and Drug Administration approved a new pain management drug which could change the way healthcare ...

The FDA on Thursday approved a new class of pain medication that provides an alternative to opioids. It will be sold under ...

Mumbai: The Vegetarian Society will hold its bi-monthly talk on Thursday, February 13, at Samrat Restaurant, Churchgate ...

The U.S. Food and Drug Administration (FDA) approved Thursday a new type of prescription pain medication for moderate to ...

While New Orleans prepares for the excitement of the big game, it’s important to remember that sports injuries aren’t limited to the professionals. High school athletes, weekend warriors, and generall ...

The U.S. Food and Drug Administration (FDA) approved Journavx (suzetrigine) oral tablets on Thursday as a first-in-class ...

The traditional Chinese practice of qigong can effectively alleviate chronic low back pain (CLBP), according to a study ...